Showing results (361-370 of 448) with videos related to
Sort By:
Pageof 45
Scanning Electron Microscopy|January 1, 1980
Model system for the study of inital damage to arterial endothelial cells in situ by scanning electron microscopyA W Sedar, M J Silver, C M Ingerman, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 1, 1990
Paternal mononuclear cell immunization therapy for repeated miscarriage: predictive variables for pregnancy successF S Cowchock, J B Smith, S David, et al.Urology|August 1, 1987
Effects of cyclophosphamide alone and scheduled methotrexate-5-fluorouracil combination chemotherapy on transplantable R-3327 prostatic adenocarcinoma in F1 hybrid male ratJ B Smith, P Y Ghayad, C B Dhabuwala, et al.American Journal of Medical Genetics|May 1, 1987
Preliminary evidence for genetic determination of intraerythrocytic sodium concentration in Utah pedigreesM M Dadone, J B Smith, L Wu, et al.Biochemical and Biophysical Research Communications|November 1, 2002
Functional improvement of antibody fragments using a novel phage coat protein III fusion systemKim Bak Jensen, Martin Larsen, Jesper Søndergaard Pedersen, et al.The American Journal of Pathology|August 1, 1981
Effects of heparin on platelet aggregation and release and thromboxane A2 productionS F Mohammad, W H Anderson, J B Smith, et al.British Journal of Pharmacology|February 1, 1983
Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analoguesS E Burke, A M Lefer, K C Nicolaou, et al.Clinical Obstetrics and Gynecology|December 1, 1996
Prenatal diagnosis using fetal cells isolated from maternal peripheral blood: a reviewC D Steele, R J Wapner, J B Smith, et al.Journal of Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1985
Differences in the mode of action of 1-oleoyl-2-acetyl-glycerol and phorbol ester in platelet activationB Ashby, M A Kowalska, E Wernick, et al.Prostaglandins, Leukotrienes, and Medicine|June 1, 1983
Urinary excretion of prostacyclin and thromboxane A2 metabolites after angiotensin converting enzyme inhibition in hypertensive patientsP H Vlasses, R K Ferguson, J B Smith, et al.Pageof 45